142 related articles for article (PubMed ID: 9088539)
1. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
3. Opioid diketopiperazines: synthesis and activity of a prototypic class of opioid antagonists.
Balboni G; Guerrini R; Salvadori S; Tomatis R; Bryant SD; Bianchi C; Attila M; Lazarus LH
Biol Chem; 1997 Jan; 378(1):19-29. PubMed ID: 9049061
[TBL] [Abstract][Full Text] [Related]
4. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
5. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
[TBL] [Abstract][Full Text] [Related]
6. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
Wilkes BC; Schiller PW
Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
[TBL] [Abstract][Full Text] [Related]
7. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
[TBL] [Abstract][Full Text] [Related]
8. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
9. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
Carpenter KA; Wilkes BC; Weltrowska G; Schiller PW
Eur J Biochem; 1996 Nov; 241(3):756-64. PubMed ID: 8944763
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
12. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
13. X-ray structure of Tyr-D-Tic-Phe-Phe-NH2 (D-TIPP-NH2), a highly potent mu-receptor selective opioid agonist. Comparison with proposed model structures.
Flippen-Anderson JL; Deschamps JR; George C; Reddy PA; Lewin AH; Brine GA; Sheldrick G; Nikiforovich G
J Pept Res; 1997 May; 49(5):384-93. PubMed ID: 9211219
[TBL] [Abstract][Full Text] [Related]
14. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent delta-opioid antagonist.
Lovekamp T; Cooper PS; Hardison J; Bryant SD; Guerrini R; Balboni G; Salvadori S; Lazarus LH
Brain Res; 2001 May; 902(1):131-4. PubMed ID: 11376603
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonism by Dmt-Tic analogues and HS 378, a naltrindole analogue.
Labarre M; Butterworth J; St-Onge S; Payza K; Schmidhammer H; Salvadori S; Balboni G; Guerrini R; Bryant SD; Lazarus LH
Eur J Pharmacol; 2000 Oct; 406(1):R1-3. PubMed ID: 11011049
[TBL] [Abstract][Full Text] [Related]
18. Solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.
Ciajolo MR; Balboni G; Picone D; Salvadori S; Tancredi T; Temussi PA; Tuzi A
Int J Pept Protein Res; 1995 Aug; 46(2):134-8. PubMed ID: 8567167
[TBL] [Abstract][Full Text] [Related]
19. Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptors.
Tryoen-Tóth P; Décaillot FM; Filliol D; Befort K; Lazarus LH; Schiller PW; Schmidhammer H; Kieffer BL
J Pharmacol Exp Ther; 2005 Apr; 313(1):410-21. PubMed ID: 15590769
[TBL] [Abstract][Full Text] [Related]
20. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception.
Su YF; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):815-23. PubMed ID: 9864259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]